Estrogen biosynthesis and signaling in endometriosis

Molecular and Cellular Endocrinology

Volumn 358, Issue 2, 2012, Pages 146-154

  Huhtinen, Kaisa ^a,b   Ståhle, Mia ^a   Perheentupa, Antti ^a,b   Poutanen, Matti ^a  

^a UNIVERSITY OF TURKU   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

Author keywords

Aromatase; Coregulator; Estrogen receptor; Hydroxysteroid (17beta) dehydrogenase; Pre receptor regulation; Steroidogenesis

Indexed keywords

ANDROSTENEDIONE; AROMATASE; CHOLESTEROL MONOOXYGENASE (SIDE CHAIN CLEAVING); ESTRADIOL; ESTRADIOL SULFATE; ESTROGEN; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTRONE; ESTRONE SULFATE; G PROTEIN COUPLED RECEPTOR 30; LIGAND; PRASTERONE; PRASTERONE SULFATE; PROLINE GLUTAMIC ACID LEUCINE RICH PROTEIN 1; RECEPTOR INTERACTING PROTEIN 140; REGULATOR PROTEIN; STEROID 17ALPHA MONOOXYGENASE; STEROID RECEPTOR COACTIVATOR 1; STEROIDOGENIC ACUTE REGULATORY PROTEIN; STERYL SULFATASE; TESTOSTERONE 17BETA DEHYDROGENASE; TESTOSTERONE 17BETA DEHYDROGENASE 2; UNCLASSIFIED DRUG;

CELL PROLIFERATION; CELL SPECIFICITY; DEEP ENDOMETRIOSIS; ENDOMETRIOSIS; ENZYME INACTIVATION; ESTROGEN RELEASE; ESTROGEN SYNTHESIS; HORMONAL REGULATION; HUMAN; LIGAND BINDING; METRITIS; OVARY ENDOMETRIOSIS; PATHOGENESIS; PERITONEAL ENDOMETRIOSIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION;

ANIMALS; ENDOMETRIOSIS; ESTROGENS; FEMALE; HUMANS; MODELS, BIOLOGICAL; OVARY; RECEPTORS, ESTROGEN; SIGNAL TRANSDUCTION;

EID: 84861531117     PISSN: 03037207     EISSN: 18728057     Source Type: Journal    
DOI: 10.1016/j.mce.2011.08.022     Document Type: Review

References (82)

1. Attar E., Bulun S. Aromatase and other steroidogenic genes in endometriosis: translational aspects. Human Reproduction Update 2006, 12:49-56.
2. Attar E., Tokunaga H., Imir G., Yilmaz M., Redwine D., Putman M., Gurates B., Attar R., Yaegashi N., Hales D., Bulun S. Prostaglandin E2 via steroidogenic factor-1 coordinately regulates transcription of steroidogenic genes necessary for estrogen synthesis in endometriosis. Journal of Clinical Endocrinology and Metabolism 2009, 94:623-631.
3. Attia G., Zeitoun K., Edwards D., Johns A., Carr B., Bulun S. Progesterone receptor isoform A but not B is expressed in endometriosis. Journal of Clinical Endocrinology and Metabolism 2000, 85:2897-2902.
4. Banz C., Ungethuem U., Kuban R.J., Diedrich K., Lengyel E., Hornung D. The molecular signature of endometriosis-associated endometrioid ovarian cancer differs significantly from endometriosis-independent endometrioid ovarian cancer. Fertility and Sterility 2010, 94:1212-1217.
5. Borghese B., Mondon F., Noël J., Fayt I., Mignot T., Vaiman D., Chapron C. Gene expression profile for ectopic versus eutopic endometrium provides new insights into endometriosis oncogenic potential. Molecular Endocrinology 2008, 22:2557-2562.
6. Brandenberger A., Lebovic D., Tee M., Ryan I., Tseng J., Jaffe R., Taylor R. Oestrogen receptor (ER)-alpha and ER-beta isoforms in normal endometrial and endometriosis-derived stromal cells. Molecular Human Reproduction 1999, 5:651-655.
7. Bukulmez O., Hardy D., Carr B., Word R., Mendelson C. Inflammatory status influences aromatase and steroid receptor expression in endometriosis. Endocrinology 2008, 149:1190-1204.
8. Bulun S. Endometriosis. The New England Journal of Medicine 2009, 360:268-279.
9. Bulun S., Rosenthal I., Brodie A., Inkster S., Zeller W., DiGeorge A., Frasier S., Kilgore M., Simpson E. Use of tissue-specific promoters in the regulation of aromatase cytochrome P450 gene expression in human testicular and ovarian sex cord tumors, as well as in normal fetal and adult gonads. Journal of Clinical Endocrinology and Metabolism 1993, 77:1616-1621.
10. Bulun S., Simpson E. Competitive reverse transcription-polymerase chain reaction analysis indicates that levels of aromatase cytochrome P450 transcripts in adipose tissue of buttocks, thighs, and abdomen of women increase with advancing age. Journal of Clinical Endocrinology and Metabolism 1994, 78:428-432.
11. Bulun S., Utsunomiya H., Lin Z., Yin P., Cheng Y., Pavone M., Tokunaga H., Trukhacheva E., Attar E., Gurates B., Milad M., Confino E., Su E., Reierstad S., Xue Q. Steroidogenic factor-1 and endometriosis. Molecular and Cellular Endocrinology 2009, 300:104-108.
12. Caballero V., Ruiz R., Sainz J.A., Cruz M., López-Nevot M.A., Galán J.J., Real L.M., de Castro F., López-Villaverde V., Ruiz A. Preliminary molecular genetic analysis of the Receptor Interacting Protein 140 (RIP140) in women affected by endometriosis. Journal of Experimental and Clinical Assisted Reproduction 2005, 2:11.
13. Carlström K., Bergqvist A., Ljungberg O. Metabolism of estrone sulfate in endometriotic tissue and in uterine endometrium. Fertility and Sterility 1988, 49:229-233.
14. Carneiro M., Morsch D., Camargos A., Spritzer P., Reis F. Expression of 17beta-hydroxysteroid dehydrogenase type 2 in pelvic endometriosis. Gynecological Endocrinology 2007, 23:188-192.
15. Casey M.L., MacDonald P.C., Andersson S. 17 beta-Hydroxysteroid dehydrogenase type 2: chromosomal assignment and progestin regulation of gene expression in human endometrium. Journal of Clinical Investigation 1994, 94:2135-2141.
16. Cavallini, A., Resta, L., Caringella, A.M., Dinaro, E., Lippolis, C., Loverro, G., 2011. Involvement of estrogen receptor-related receptors in human ovarian endometriosis. Fertil Steril 96, 102-6.Cheng, Y., Imir, A., Fenkci, V., Yilmaz, M., Bulun, S., 2007. Stromal cells of endometriosis fail to produce paracrine factors that induce epithelial 17beta-hydroxysteroid dehydrogenase type 2 gene and its transcriptional regulator Sp1: a mechanism for defective estradiol metabolism. Am J Obstet Gynecol 196, 391.e391-397; discussion 391.e397-398.
17. Cheng Y., Yin P., Xue Q., Yilmaz B., Dawson M., Bulun S. Retinoic acid (RA) regulates 17beta-hydroxysteroid dehydrogenase type 2 expression in endometrium: interaction of RA receptors with specificity protein (SP) 1/SP3 for estradiol metabolism. Journal of Clinical Endocrinology and Metabolism 2008, 93:1915-1923.
18. Colette S., Defrère S., Lousse J.C., Van Langendonckt A., Gotteland J.P., Loumaye E., Donnez J. Inhibition of steroid sulfatase decreases endometriosis in an in vivo murine model. Human Reproduction 2011, 26:1362-1370.
19. Colette S., Lousse J., Defrère S., Curaba M., Heilier J., Van Langendonckt A., Mestdagt M., Foidart J., Loumaye E., Donnez J. Absence of aromatase protein and mRNA expression in endometriosis. Human Reproduction 2009, 24:2133-2141.
20. Cvoro A., Tatomer D., Tee M., Zogovic T., Harris H., Leitman D. Selective estrogen receptor-beta agonists repress transcription of proinflammatory genes. Journal of Immunology 2008, 180:630-636.
21. Dassen H., Punyadeera C., Kamps R., Delvoux B., Van Langendonckt A., Donnez J., Husen B., Thole H., Dunselman G., Groothuis P. Estrogen metabolizing enzymes in endometrium and endometriosis. Human Reproduction 2007, 22:3148-3158.
22. Delvoux B., Groothuis P., D'Hooghe T., Kyama C., Dunselman G., Romano A. Increased production of 17beta-estradiol in endometriosis lesions is the result of impaired metabolism. Journal of Clinical Endocrinology and Metabolism 2009, 94:876-883.
23. Deng L., Shipley G., Loose-Mitchell D., Stancel G., Broaddus R., Pickar J., Davies P. Coordinate regulation of the production and signaling of retinoic acid by estrogen in the human endometrium. Journal of Clinical Endocrinology and Metabolism 2003, 88:2157-2163.
24. Einspanier A., Lieder K., Brüns A., Husen B., Thole H., Simon C. Induction of endometriosis in the marmoset monkey (Callithrix jacchus). Molecular Human Reproduction 2006, 12:291-299.
25. Fritah A., Christian M., Parker M.G. The metabolic coregulator RIP140: an update. American Journal of Physiology, Endocrinology and Metabolism 2010, 299:E335-E340.
26. Fujimoto J., Hirose R., Sakaguchi H., Tamaya T. Expression of oestrogen receptor-alpha and -beta in ovarian endometriomata. Molecular Human Reproduction 1999, 5:742-747.
27. Gao F., Ma X., Ostmann A.B., Das S.K. GPR30 Activation Opposes Estrogen-Dependent Uterine Growth via Inhibition of Stromal ERK1/2 and Estrogen Receptor Alpha (ER{alpha}) Phosphorylation Signals. Endocrinology 2011, 152:1434-1447.
28. Ghersevich S., Poutanen M., Martikainen H., Vihko R. Expression of 17 beta-hydroxysteroid dehydrogenase in human granulosa cells: correlation with follicular size, cytochrome P450 aromatase activity and oestradiol production. Journal of Endocrinology 1994, 143:139-150.
29. Giudice L. Clinical practice Endometriosis. The New England Journal of Medicine 2010, 362:2389-2398.
30. Hammes S.R., Levin E.R. Extranuclear steroid receptors: nature and actions. Endocrine Reviews 2007, 28:726-741.
31. Harada N. A unique aromatase (P-450AROM) mRNA formed by alternative use of tissue-specific exons 1 in human skin fibroblasts. Biochemical and Biophysical Research Communications 1992, 189:1001-1007.
32. Harris H.A., Bruner-Tran K.L., Zhang X., Osteen K.G., Lyttle C.R. A selective estrogen receptor-beta agonist causes lesion regression in an experimentally induced model of endometriosis. Human Reproduction 2005, 20:936-941.
33. He Y.Y., Cai B., Yang Y.X., Liu X.L., Wan X.P. Estrogenic G protein-coupled receptor 30 signaling is involved in regulation of endometrial carcinoma by promoting proliferation, invasion potential, and interleukin-6 secretion via the MEK/ERK mitogen-activated protein kinase pathway. Cancer Science 2009, 100:1051-1061.
34. Heilier J., Donnez O., Van Kerckhove V., Lison D., Donnez J. Expression of aromatase (P450 aromatase/CYP19) in peritoneal and ovarian endometriotic tissues and deep endometriotic (adenomyotic) nodules of the rectovaginal septum. Fertility and Sterility 2006, 85:1516-1518.
35. Hsu C.C., Lu C.W., Huang B.M., Wu M.H., Tsai S.J. Cyclic adenosine 3',5'-monophosphate response element-binding protein and CCAAT/enhancer-binding protein mediate prostaglandin E2-induced steroidogenic acute regulatory protein expression in endometriotic stromal cells. American Journal of Pathology 2008, 173:433-441.
36. Hudelist G., Czerwenka K., Keckstein J., Haas C., Fink-Retter A., Gschwantler-Kaulich D., Kubista E., Singer C. Expression of aromatase and estrogen sulfotransferase in eutopic and ectopic endometrium: evidence for unbalanced estradiol production in endometriosis. Reproduction Science 2007, 14:798-805.
37. Kitawaki J., Noguchi T., Amatsu T., Maeda K., Tsukamoto K., Yamamoto T., Fushiki S., Osawa Y., Honjo H. Expression of aromatase cytochrome P450 protein and messenger ribonucleic acid in human endometriotic and adenomyotic tissues but not in normal endometrium. Biology of Reproduction 1997, 57:514-519.
38. Kolkova Z., Noskova V., Ehinger A., Hansson S., Casslén B. G protein-coupled estrogen receptor 1 (GPER, GPR 30) in normal human endometrium and early pregnancy decidua. Molecular Human Reproduction 2010, 16:743-751.
39. Kumagami, A., Ito, A., Yoshida-Komiya, H., Fujimori, K., Sato, A., 2011. Expression patterns of the steroid receptor co-activator family in human ovarian endometriosis. Journal of obstetrics & gynaecology Research, in press. doi:10.1111/j.1447-0756.2010.01509.x.
40. Kyama C., Overbergh L., Mihalyi A., Meuleman C., Mwenda J., Mathieu C., D'Hooghe T. Endometrial and peritoneal expression of aromatase, cytokines, and adhesion factors in women with endometriosis. Fertility and Sterility 2008, 89:301-310.
41. Labrie F. Intracrinology. Molecular and Cellular Endocrinology 1991, 78:C113-C118.
42. Lin B., Suzawa M., Blind R., Tobias S., Bulun S., Scanlan T., Ingraham H. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Research 2009, 69:5415-5423.
43. Marchais-Oberwinkler S., Henn C., Möller G., Klein T., Negri M., Oster A., Spadaro A., Werth R., Wetzel M., Xu K., Frotscher M., Hartmann R.W., Adamski J. 17β-Hydroxysteroid dehydrogenases (17β-HSDs) as therapeutic targets: protein structures, functions, and recent progress in inhibitor development. Journal of Steroid Biochemistry and Molecular Biology 2011, 125:66-82.
44. Matsuzaki S., Canis M., Pouly J., Botchorishvili R., Déchelotte P., Mage G. Differential expression of genes in eutopic and ectopic endometrium from patients with ovarian endometriosis. Fertility and Sterility 2006, 86:548-553.
45. Matsuzaki S., Canis M., Pouly J., Déchelotte P., Mage G. Analysis of aromatase and 17beta-hydroxysteroid dehydrogenase type 2 messenger ribonucleic acid expression in deep endometriosis and eutopic endometrium using laser capture microdissection. Fertility and Sterility 2006, 85:308-313.
46. Matsuzaki S., Murakami T., Uehara S., Canis M., Sasano H., Okamura K. Expression of estrogen receptor alpha and beta in peritoneal and ovarian endometriosis. Fertility and Sterility 2001, 75:1198-1205.
47. Moeller G., Adamski J. Multifunctionality of human 17beta-hydroxysteroid dehydrogenases. Molecular and Cellular Endocrinology 2006, 248:47-55.
48. Moeller G., Adamski J. Integrated view on 17beta-hydroxysteroid dehydrogenases. Molecular and Cellular Endocrinology 2009, 301:7-19.
49. Musgrove E.A., Sutherland R.L. Biological determinants of endocrine resistance in breast cancer. Nature Reviews Cancer 2009, 9:631-643.
50. Noble L., Simpson E., Johns A., Bulun S. Aromatase expression in endometriosis. Journal of Clinical Endocrinology and Metabolism 1996, 81:174-179.
51. Noble L., Takayama K., Zeitoun K., Putman J., Johns D., Hinshelwood M., Agarwal V., Zhao Y., Carr B., Bulun S. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells. Journal of Clinical Endocrinology and Metabolism 1997, 82:600-606.
52. Noël J.C., Anaf V., Borghese B., Vaiman D., Fayt I., Chapron C. The steroidogenic factor-1 protein is not expressed in various forms of endometriosis but is strongly present in ovarian cortical or medullary mesenchymatous cells adjacent to endometriotic foci. Fertility and Sterility 2011, 95:2655-2657.
53. Pasqualini J. Estrogen sulfotransferases in breast and endometrial cancers. Annals of the New York Academy of Sciences 2009, 1155:88-98.
54. Pasqualini J., Gelly C., Nguyen B., Vella C. Importance of estrogen sulfates in breast cancer. Journal of Steroid Biochemistry 1989, 34:155-163.
55. Pavone M.E., Reierstad S., Sun H., Milad M., Bulun S.E., Cheng Y.H. Altered retinoid uptake and action contributes to cell survival in endometriosis. Journal of Clinical Endocrinology and Metabolism 2010, 95:E300-E309.
56. Pavone M.E., Dyson M., Reierstad S., Pearson E., Ishikawa, Cheng Y.H.H., Bulun S.E. Endometriosis express a molecular pattern cosistent with decreased retinoid uptake, metabolism and action. Human Reproduction 2011, 26:2157-2164.
57. Puranen T., Kurkela R., Lakkakorpi J., Poutanen M., Itäranta P., Melis J., Ghosh D., Vihko R., Vihko P. Characterization of molecular and catalytic properties of intact and truncated human 17beta-hydroxysteroid dehydrogenase type 2 enzymes: intracellular localization of the wild-type enzyme in the endoplasmic reticulum. Endocrinology 1999, 140:3334-3341.
58. Purohit A., Fusi L., Brosens J., Woo L., Potter B., Reed M. Inhibition of steroid sulphatase activity in endometriotic implants by 667 COUMATE: a potential new therapy. Human Reproduction 2008, 23:290-297.
59. Rantakari P., Strauss L., Kiviranta R., Lagerbohm H., Paviala J., Holopainen I., Vainio S., Pakarinen P., Poutanen M. Placenta defects and embryonic lethality resulting from disruption of mouse hydroxysteroid (17-beta) dehydrogenase 2 gene. Molecular Endocrinology 2008, 22:665-675.
60. Ray P., Ghosh S., Zhang D., Ray A. Repression of interleukin-6 gene expression by 17 beta-estradiol: inhibition of the DNA-binding activity of the transcription factors NF-IL6 and NF-kappa B by the estrogen receptor. FEBS Letters 1997, 409:79-85.
61. Rizner T. Estrogen metabolism and action in endometriosis. Molecular and Cellular Endocrinology 2009, 307:8-18.
62. Rubin G., Harrold A., Mills J., Falany C., Coughtrie M. Regulation of sulphotransferase expression in the endometrium during the menstrual cycle, by oral contraceptives and during early pregnancy. Molecular Human Reproduction 1999, 5:995-1002.
63. Shang Y. Molecular mechanisms of oestrogen and SERMs in endometrial carcinogenesis. Nature Reviews Cancer 2006, 6:360-368.
64. Simpson E. Sources of estrogen and their importance. Journal of Steroid Biochemistry and Molecular Biology 2003, 86:225-230.
65. Smuc T., Hevir N., Ribic-Pucelj M., Husen B., Thole H., Rizner T. Disturbed estrogen and progesterone action in ovarian endometriosis. Molecular and Cellular Endocrinology 2009, 301:59-64.
66. Smuc T., Pucelj M., Sinkovec J., Husen B., Thole H., Lanisnik Rizner T. Expression analysis of the genes involved in estradiol and progesterone action in human ovarian endometriosis. Gynecological Endocrinology 2007, 23:105-111.
67. Sugawara T., Abe S., Sakuragi N., Fujimoto Y., Nomura E., Fujieda K., Saito M., Fujimoto S. RIP 140 modulates transcription of the steroidogenic acute regulatory protein gene through interactions with both SF-1 and DAX-1. Endocrinology 2001, 142:3570-3577.
68. Suzuki A., Horiuchi A., Oka K., Miyamoto T., Kashima H., Shiozawa T. Immunohistochemical detection of steroid receptor cofactors in ovarian endometriosis: involvement of down-regulated SRC-1 expression in the limited growth activity of the endometriotic epithelium. Virchows Archiv 2010, 456:433-441.
69. Tamura M., Deb S., Sebastian S., Okamura K., Bulun S.E. Estrogen up-regulates cyclooxygenase-2 via estrogen receptor in human uterine microvascular endothelial cells. Fertility and Sterility 2004, 81:1351-1356.
70. Trukhacheva E., Lin Z., Reierstad S., Cheng Y., Milad M., Bulun S. Estrogen receptor (ER) beta regulates ERalpha expression in stromal cells derived from ovarian endometriosis. Journal of Clinical Endocrinology and Metabolism 2009, 94:615-622.
71. Tsai S., Wu M., Lin C., Sun H., Chen H. Regulation of steroidogenic acute regulatory protein expression and progesterone production in endometriotic stromal cells. Journal of Clinical Endocrinology and Metabolism 2001, 86:5765-5773.
72. Utsunomiya H., Cheng Y., Lin Z., Reierstad S., Yin P., Attar E., Xue Q., Imir G., Thung S., Trukhacheva E., Suzuki T., Sasano H., Kim J., Yaegashi N., Bulun S. Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis. Molecular Endocrinology 2008, 22:904-914.
73. Vadlamudi R.K., Rajhans R., Chakravarty D., Nair B.C., Nair S.S., Evans D.B., Chen S., Tekmal R.R. Regulation of aromatase induction by nuclear receptor coregulator PELP1. Journal of Steroid Biochemistry and Molecular Biology 2010, 118:211-218.
74. Velasco I., Rueda J., Acién P. Aromatase expression in endometriotic tissues and cell cultures of patients with endometriosis. Molecular Human Reproduction 2006, 12:377-381.
75. Vouk K., Smuc T., Guggenberger C., Ribič-Pucelj M., Sinkovec J., Husen B., Thole H., Houba P., Thaete C., Adamski J., Rižner T.L. Novel estrogen-related genes and potential biomarkers of ovarian endometriosis identified by differential expression analysis. Journal of Steroid Biochemistry and Molecular Biology 2011, 125:231-242.
76. Wei L.N. Retinoids and receptor interacting protein 140 (RIP140) in gene regulation. Current Medicinal Chemistry 2004, 11:1527-1532.
77. Xiu-li W., Wen-jun C., Hui-hua D., Su-ping H., Shi-long F. ERB-041, a selective ER beta agonist, inhibits iNOS production in LPS-activated peritoneal macrophages of endometriosis via suppression of NF-kappaB activation. Molecular Immunology 2009, 46:2413-2418.
78. Xue Q., Lin Z., Cheng Y., Huang C., Marsh E., Yin P., Milad M., Confino E., Reierstad S., Innes J., Bulun S. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biology of Reproduction 2007, 77:681-687.
79. Yang S., Fang Z., Gurates B., Tamura M., Miller J., Ferrer K., Bulun S.E. Stromal PRs mediate induction of 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrial epithelium: a paracrine mechanism for inactivation of E2. Molecular Endocrinology 2001, 15:2093-2105.
80. Zeitoun K., Takayama K., Sasano H., Suzuki T., Moghrabi N., Andersson S., Johns A., Meng L., Putman M., Carr B., Bulun S. Deficient 17beta-hydroxysteroid dehydrogenase type 2 expression in endometriosis: failure to metabolize 17beta-estradiol. Journal of Clinical Endocrinology and Metabolism 1998, 83:4474-4480.
81. Zhongyi S., Rantakari P., Lamminen T., Toppari J., Poutanen M. Transgenic male mice expressing human hydroxysteroid dehydrogenase 2 indicate a role for the enzyme independent of its action on sex steroids. Endocrinology 2007, 148:3827-3836.
82. Zschiedrich I., Hardeland U., Krones-Herzig A., Berriel Diaz M., Vegiopoulos A., Müggenburg J., Sombroek D., Hofmann T.G., Zawatzky R., Yu X., Gretz N., Christian M., White R., Parker M.G., Herzig S. Co-activator function of RIP140 for NFkappaB/RelA-dependent cytokine gene expression. Blood 2008, 112:264-276.